Call now (786) 988 2538
Embedded Files
“After years of waiting, just one hour for answers.”
Our advanced ultrasound examination is designed to provide clear, meaningful diagnostic information in a single visit, helping replace long periods of uncertainty with understanding and direction.
A Leader in Endometriosis Mapping and Dynamic 3D Pelvic Floor Ultrasound
Welcome to Novasono, a clinical innovation company advancing the diagnosis of complex women’s health conditions through evidence-based ultrasound. We focus on two of the most underdiagnosed and consequential disorders in women’s healthcare, endometriosis and pelvic floor dysfunction, conditions that affect millions of women yet often remain unrecognized for years.
Our approach replaces delayed, invasive, and high-cost diagnostic pathways with real-time, non-invasive, radiation-free imaging that delivers precise, actionable answers in a single visit. What distinguishes Novasono is not new technology, but structured expertise: standardized ultrasound protocols, advanced interpretation, and clinically integrated reporting.
Novasono brings clarity where uncertainty has persisted, redefining the standard of care for endometriosis and pelvic floor disorders.
Endometriosis Mapping Ultrasound
If you think you may have endometriosis, don’t wait.
Get mapped. Get diagnosed earlier. Avoid unnecessary surgery.
Your body deserves answers now—not ten years from now.
3D Dynamic Pelvic Floor Ultrasound
Do you leak urine when you laugh, cough, exercise, or lift?
These symptoms are common signs of pelvic floor dysfunction, not something you have to live with.
A 3D dynamic pelvic floor ultrasound can identify the cause of urinary incontinence and guide the right treatment, non-invasively and without radiation.
One exam. Clear answers. A better path forward.
Endometriosis
6.5–10 million U.S. women affected
6–10% prevalence among reproductive-age women
35–50% among women with infertility
Up to 70% among those with pelvic pain/dysmenorrhea
200,000–250,000 new diagnosed cases/year—but true incidence far higher
(WHO, U.S. estimates)
Diagnostic delay of 7-10 years
Pelvic Floor Dysfunction
39 million U.S. women affected
25% prevalence among adult women ≥20 years (NHANES)
10–15% prevalence ages 20–39
30% ages 40–59
40–50% ages ≥60
11–20% lifetime risk of surgery for prolapse or incontinence
Years to correct diagnosis common, with symptoms often normalized, misattributed, or treated empirically without identifying the underlying mechanism.
Compassionate, Patient-Centered Care
We listen first. Our team prioritizes empathy, trust, and clear communication to assist women who have often waited years for answers.
Integrated Clinical Approach
We work closely with referring physicians to support informed decisions through accurate disease mapping and clear reporting.
Specialized Expertise
Our strength lies in focused experience and structured expertise to encourage earlier diagnosis for conditions long overlooked.
Page updated
Google Sites
Report abuse